Evidence map›Paper›PMID 25741248›Full record

ArticleFrontiers in systems neuroscience2015

A survey of substance use for cognitive enhancement by university students in the Netherlands.

Kimberly J Schelle, Bas M J Olthof, Wesley Reintjes, Carsten Bundt, Joyce Gusman-Vermeer, Anke C C M van Mil

Open access · goldAbstract read
In one paragraph

Article in Frontiers in systems neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neuroenhancement in French and Romanian University Students, Motivations and Associated Factors.International journal of environmental research and public health · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Methylphenidate boosts choices of mental labor over leisure depending on striatal dopamine synthesis capacity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Kimberly J SchelleRadboud Honours Academy, Radboud University Nijmegen, Netherlands ; Department of Industrial Design, Eindhoven University of Technology Eindhoven, Netherlands.
Bas M J OlthofRadboud Honours Academy, Radboud University Nijmegen, Netherlands ; Faculty of Medical Sciences, Institute of Neuroscience, Newcastle University Newcastle upon Tyne, UK.
Wesley ReintjesRadboud Honours Academy, Radboud University Nijmegen, Netherlands ; Department of Neurology, Isala Clinics Zwolle, Netherlands.
Carsten BundtRadboud Honours Academy, Radboud University Nijmegen, Netherlands ; Department of Experimental Psychology, Ghent University Ghent, Belgium.
Joyce Gusman-VermeerRadboud Honours Academy, Radboud University Nijmegen, Netherlands.
Anke C C M van MilRadboud Honours Academy, Radboud University Nijmegen, Netherlands ; Department of Physiology, Radboud Institute for Health Sciences, Radboud University Medical Center Nijmegen, Netherlands.
Radboud University Nijmegen · NLIsala · NLRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPharmacological cognitive enhancement, using chemicals to change cellular processes in the brain in order to enhance one's cognitive capacities, is an often discussed phenomenon. The prevalence among Dutch university students is unknown.

methodsThe study set out to achieve the following goals: (1) give an overview of different methods in order to assess the prevalence of use of prescription, illicit and lifestyle drugs for cognitive enhancement (2) investigate whether polydrug use and stress have a relationship with cognitive enhancement substance use (3) assessing opinions about cognitive enhancement prescription drug use. A nationwide survey was conducted among 1572 student respondents of all government supported Dutch universities.

resultsThe most detailed level of analysis-use of specific substances without a prescription and with the intention of cognitive enhancement-shows that prescription drugs, illicit drugs and lifestyle drugs are respectively used by 1.7, 1.3, and 45.6% of the sample. The use of prescription drugs and illicit drugs is low compared to other countries. We have found evidence of polydrug use in relation to cognitive enhancement. A relation between stress and the use of lifestyle drugs for cognitive enhancement was observed. We report the findings of several operationalizations of cognitive enhancement drug use to enable comparison with a wider variety of previous and upcoming research.

conclusionsRESULTS of this first study among university students in the Netherlands revealed a low prevalence of cognitive enhancement drug use compared to other countries. Multiple explanations, such as a difference in awareness of pharmacological cognitive enhancement among students, accessibility of drugs in the student population and inclusion criteria of enhancement substances are discussed. We urge enhancement researchers to take the different operationalizations and their effects on the prevalence numbers into account.

Indexed as

cognitive enhancementillicit drugslifestyle drugsneuroenhancementnon-medical useprescription stimulantsself-reportsmart drugs

Identifiers

PMID25741248
PMCPMC4330699
OpenAlexW2030417956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.